Form4.ai tracks every SEC insider trade in real time. See every HEPA insider filing with a free account — no card.

See every HEPA insider filing

Free account

Hepion Pharmaceuticals, Inc. (HEPA) Insider Trading

Hepion Pharmaceuticals, Inc. (HEPA) has 22 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $825K. Most recent filing: Oct. 27, 2026.

Bought vs sold

Open-market value, last 90 days

Bought: $825K (100%)
  • Bought $825K · 100%

What insiders filed

Form 4 filings by type, last 90 days

Buys: 5 (23%) Grants, exercises & other: 17 (77%)
  • Buys 5 · 23%
  • Grants, exercises & other 17 · 77%

At a glance

Insiders trading
8
Largest buy
—
Most recent filing
Oct 27, 2026

Latest HEPA Form 4 filings

Date Insider Trade Value Price since buy
Oct 27, 2026 SEC filing Stetz Gary S. Chief Financial Officer Holdings only — —
Oct 27, 2026 SEC filing Fisher Danina Director Holdings only — —
Oct 27, 2026 SEC filing Liddy James Gordon Director Holdings only — —

See every HEPA insider trade

Create a free account to see all 22 HEPA filings from the last 90 days. No card needed.

Create free account

Want HEPA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.